Skip to content

Effectiveness Of Acceptance and Commitment Therapy on male smokers

Controlled trial of effectiveness of Acceptance and Commitment Therapy on depression, anxiety, risky decision making, craving and cessation in male smokers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017011932057N1
Enrollment
70
Registered
2017-06-19
Start date
2017-02-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: nicotine dependence. Condition 2: depression. Condition 3: anxiety. Mental and behavioural disorders due to use of tobacco Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities. Anxiety NOS

Interventions

Intervention 1: Intervention group: This study is conducted to determine the effectiveness of Acceptance and Commitment Therapy (ACT) on depression, anxiety, risky decision making, craving and cessati
Behavior
Control Group: This group will receive behavioral interventions for smoking cessation that approved by the Ministry of Health of Iran that is used for the smoking cessation centers and based on the ps
Intervention group: This study is conducted to determine the effectiveness of Acceptance and Commitment Therapy (ACT) on depression, anxiety, risky decision making, craving and cessation in male smoke

Sponsors

Vice chancellor for research of Kashan University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:1.Having an age of 18–40 years, 2.Having a degree in secondary education or higher, 3.nicotine dependence based on DSM 5 diagnostic criteria exclusion criteria:1.Having a known-cause depression or anxiety following problems such as loss, marital conflicts and divorce, 2.Having a history of psychotic disorders, 3.Receiving psychotherapy or drug therapy during past six months, 4.Unwillingness to continue participating in the study , 5.Failing to participate in more than two sessions of the study intervention 6.Had a history of substance abuse disorders;

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: Beck depression inventory.;Anxiety. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: Beck Anxiety Inventory.;Craving(nicotine dependence). Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: fagestrom Craving scale.;Risky decision making. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: Iowa gambling test.;Smoking cessation. Timepoint: Before intervention, After intervention, One month after intervention. Method of measurement: Expiratory CO2 concentration.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Davoudi

Kashan University of Medical Sciences and Health Services

davoudi-mr@kaums.ac.ir+98 31 5554 9111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026